Clinical Trial Update: The Combined Effect of Intravesical Botox Injections and HoLEP Surgery in Treating Benign Prostatic Hyperplasia and Overactive Bladder [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the combination of intravesical Botox injections and HoLEP surgery for benign prostatic hyperplasia and overactive bladder has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Overactive Bladder

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Benign Prostatic Hyperplasia, Overactive Bladder | Phase 4 | Status: WITHDRAWN